Corvus Pharmaceuticals Inc.

18/12/2024 | Press release | Distributed by Public on 18/12/2024 00:54

Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis